Samsung’s AI companion push could fuel a pricier upgrade cycle
Samsung Electronics is wagering that your next big home improvement won’t just be bigger displays or shinier appliances. Instead, it will be a tighter web of AI features that makes it tougher to keep up with outdated hardware. Samsung introduced its “Companion to AI Living” presentation this week at CES 2026 in Las Vegas. Leadership […]
GLP-1 Drug Market Changes; Wegovy Pill Hits Shelves; Hypercortisolism Drug Rejected
(MedPage Today) — A pill formation, a stronger injectable, and more cash payment options: lots of changes are coming to the GLP-1 drug market. (NBC News) The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk…
Semaglutide improves knee replacements for patients with diabetes
For those with type 2 diabetes who have knee osteoarthritis, getting a knee replacement can be difficult because they are more likely to have surgical complications.
Novo Nordisk launches daily weight-loss pill to expand GLP-1 access
A daily pill for weight loss has officially arrived in the U.S.
Can the US Launch of NVO’s Wegovy Pill Reignite Momentum in 2026?
Shares of Novo Nordisk NVO jumped 5.2% on Monday and about 4% in the pre-market hours today as investors cheered the U.S. launch of its newly approved Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction in the long term, and to reduce the risk of major adverse cardiovascular […]
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America – PR Newswire
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America PR Newswire Wegovy is now available as a pill. Here’s what you need to know CNN First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. CNBC Wegovy obesity pill now available at pharmacies : Shots […]
EMED PROVIDES ACCESS TO FDA-APPROVED WEGOVY® PILL THROUGH ITS TRUSTED, CLINICALLY GUIDED MODEL OF CARE
Novo Nordisk names eMed a Novocare® Recognized Care Provider for first and only oral GLP-1 for weight loss MIAMI, Jan. 6, 2026 /PRNewswire/ — eMed Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced it has been named a…
Risk for Foot Disease Modestly Lower With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in T2DM
TUESDAY, Jan. 6, 2026 — For adults with type 2 diabetes mellitus (T2DM), new users of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) have a modestly lower risk for foot disease compared with glucagon-like peptide-1 receptor agonist (GLP-1…
How eggs can help you come off Wegovy – cracking the problem of weight-regain
Oksana Mizina/Shutterstock.com For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity is treated and how people think about appetite and willpower. But their success raises an awkward question […]
In Structure licensing deal, Roche commits $100M to shore up GLP-1 position
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics.